Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer (Molecular Therapy - Oncolytics (2019) 12 (79–92), (S237277051830038X), (10.1016/j.omto.2018.12.003))

Rachael Mooney*, Asma Abdul Majid, Jennifer Batalla-Covello, Diana Machado, Xueli Liu, Joanna Gonzaga, Revathiswari Tirughana, Mohamed Hammad, Thanh H. Dellinger, Maciej S. Lesniak, David T. Curiel, Karen S. Aboody

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

https://doi.org/10.1016/j.omto.2018.12.003 (Mol Ther Oncolytics. 12, 79–92; March 29, 2019) In the original article, Dr. Thanh H. Dellinger was inadvertently omitted from the author list. He has been added to the original article online. The authors apologize for any inconvenience the original omission may have caused.

Original languageEnglish (US)
Pages (from-to)508
Number of pages1
JournalMolecular Therapy - Oncolytics
Volume17
DOIs
StatePublished - Jun 26 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer (Molecular Therapy - Oncolytics (2019) 12 (79–92), (S237277051830038X), (10.1016/j.omto.2018.12.003))'. Together they form a unique fingerprint.

Cite this